(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 3.84% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.66%.
Angiodynamics's revenue in 2023 is $335,894,000.On average, 4 Wall Street analysts forecast ANGO's revenue for 2024 to be $13,106,436,851, with the lowest ANGO revenue forecast at $13,066,112,050, and the highest ANGO revenue forecast at $13,156,524,079. On average, 4 Wall Street analysts forecast ANGO's revenue for 2025 to be $14,052,515,648, with the lowest ANGO revenue forecast at $13,986,170,991, and the highest ANGO revenue forecast at $14,121,649,570.
In 2026, ANGO is forecast to generate $14,973,172,289 in revenue, with the lowest revenue forecast at $14,973,172,289 and the highest revenue forecast at $14,973,172,289.